Technology Restrictions and Tariff Wars | Achieving Cost-Effective Alternatives in Research Products (Mindray, Eppendorf)
The U.S. government’s recent inclusion of high-end research equipment—such as flow cytometers and mass spectrometers—on its export control list has disrupted global technology supply chains. As a market leader in flow cytometry, BD faces immediate impacts, while manufacturers like Beckman Coulter and Thermo Fisher also grapple with heightened supply chain volatility. Escalating trade tensions further exacerbate the situation: since April 10, an 84% tariff on U.S. imports has drastically increased costs for American brands, eroding their market competitiveness.
2025-04-28

EN
CN
RU








